PositivePhase 2b Results from the CAN-002 Study of PP-01, an investigational product intended to mitigate Cannabis Withdrawal Syndrome in patients with Cannabis Use Disorder....
About cannabis withdrawal/cannabis use disorderThe US Government reported that in 2023 (samhsa.gov), ~19.2 million Americans had CUD with 1.64 million people receiving treatment (~500k inpatient, ~1.1 million outpatient).
... transferred during the cannabis withdrawal risk period (3-5 days after admission). The effect was particularly prominent in women, who are known to experience more severe cannabis withdrawal symptoms.